Nomura, Nobuyuki http://orcid.org/0000-0001-6516-4573
Misawa, Fuminari http://orcid.org/0000-0002-5519-9390
Fujii, Yasuo
Takeuchi, Hiroyoshi http://orcid.org/0000-0002-8844-4786
Article History
Received: 20 October 2022
Accepted: 19 November 2023
First Online: 20 January 2024
Declarations
:
: Dr. N.N. has received speaker fees from Eisai, Meiji Seika Pharma, Otsuka, and Sumitomo Pharma; and manuscript fees from Sumitomo Pharma. Dr. F.M. has received speaker fees from Eisai, Eli Lilly, Janssen, Novartis Pharma, Otsuka, Pfizer, Sumitomo Pharma. Dr. Y.F. has received speaker fees from Janssen, Novartis Pharma, and Otsuka. Dr. H.T. has received grants from Daiichi Sankyo and Novartis Pharma; speaker fees from EA Pharma, Eisai, Janssen, Kyowa, Lundbeck, Meiji Seika Pharma, Mitsubishi Tanabe Pharma, MSD, Otsuka, Sumitomo Pharma, Takeda, and Yoshitomiyakuhin; and consulting fees from Janssen, Mitsubishi Tanabe Pharma, Ono, and Sumitomo Pharma.
: This study was approved by the Yamanashi Prefectural Kita Hospital Institutional Review Board. We used the opt-out system for this study. Written informed consent was waived because this study is a retrospective design and using anonymous data. The information about this study and the opt-out system was displayed on the web.